
Statins May Improve Survival in Patients With Chronic Lymphocytic Leukemia Receiving Ibrutinib
Statin therapies significantly improved overall survival (OS) and progression-free survival (PFS) in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma (SLL; CLL/SLL) treated with ibrutinib (Imbruvica; Janssen Biotech, AbbVie). …